The Psychiatric Research Institute’s Center for Addiction Services and Treatment (CAST) relies on buprenorphine as well as individual and group therapy sessions to treat opioid addiction. No clients who have a history of severe mental illness or recent suicide attempts will be accepted into the program. Clients should also not require any medications that cannot be effectively monitored on an outpatient basis. An outside support system – family, friends, work environment – for the client should be in place before enrolling in the program. All clients must be 18 or older and able to meet the required time and financial commitments. Clients who are pregnant may want to contact the Women’s Mental Health Program to discuss treatment options.
Buprenorphine is used to treat addiction to opioid drugs, including heroin and narcotic painkillers. Buprenorphine is in a class of medications called opioid partial agonists, and can prevent withdrawal symptoms when someone stops taking opioids by producing similar effects to these drugs.
A handbook outlining all of the criteria for admission as well as the details of the program and a fee schedule is available upon request.
For more information, contact the Center for Addiction Services and Treatment at (501)526-8400.
If you are interested in finding out more about our addiction treatment research studies, you can contact the Treatment Research Unit’s research assistant/recruiter at (501) 526-8400.
Click on the links below to learn more about the programs available at CAST.